Covered recipient · General Payments record
LAURA CORDES
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$15,712.69
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $361.31 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $170.39 | 4 |
| ABBVIE INC. | $72.42 | 5 |
| Janssen Pharmaceuticals, Inc | $35.48 | 2 |
| Meditrina | $23.84 | 2 |
| Daiichi Sankyo Inc. | $23.12 | 1 |
| Sumitomo Pharma America, Inc. | $18.78 | 1 |
| Organon LLC | $17.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.26 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103503226 | CMS |
| ABBVIE INC. | $13.63 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103503228 | CMS |
| ABBVIE INC. | $13.24 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103503230 | CMS |
| ABBVIE INC. | $13.87 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103503232 | CMS |
| ABBVIE INC. | $18.42 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103503234 | CMS |
| Astellas Pharma US Inc | $13.43 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139356449 | CMS |
| Astellas Pharma US Inc | $14.43 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139362861 | CMS |
| Astellas Pharma US Inc | $17.53 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139416757 | CMS |
| Astellas Pharma US Inc | $125.00 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139429168 | CMS |
| Daiichi Sankyo Inc. | $23.12 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089411052 | CMS |
| Janssen Pharmaceuticals, Inc | $17.04 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078240857 | CMS |
| Janssen Pharmaceuticals, Inc | $18.44 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078240801 | CMS |
| Meditrina | $13.09 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154267794 | CMS |
| Meditrina | $10.75 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154267796 | CMS |
| Organon Llc | $17.28 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136192403 | CMS |
| Sumitomo Pharma America, Inc. | $18.78 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148840528 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.